"- Pharmacie - Service infirmier - Perfusion de médicaments - Préparations de médications stériles - Vaccination - Clinique Santé voyage"

During the past decade, Pharmacie Matte et Petit conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Pharmacie Matte et Petit" are "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Pharmacie Matte et Petit" in a lesser frequency.

Most popular intervention types in "Pharmacie Matte et Petit" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "MabThera" (1 trials), "PF-05280586" (1 trials), "Rituxan" (1 trials), "Rituximab-EU+ Rituximab-Pfizer x 2 Courses" (1 trials) and "Rituximab-Pfizer (PF-05280586) x 3 courses" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pharmacie Matte et Petit" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Pharmacie Matte et Petit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Pharmacie Matte et Petit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pharmacie Matte et Petit, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".